Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase NA 5Phase 1/2 3Phase 2/3 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Endocrine 3

Conditions

Neuroendocrine Tumors 43Carcinoma, Neuroendocrine 22Small Cell Lung Carcinoma 13Carcinoma, Non-Small-Cell Lung 12Neoplasms 11Sarcoma 10Lung Neoplasms 9Thyroid Carcinoma, Anaplastic 7Thyroid Cancer, Papillary 7Stomach Neoplasms 7Pheochromocytoma 7Paraganglioma 7Head and Neck Neoplasms 7Gastro-enteropancreatic neuroendocrine tumor 7Carcinoid Tumor 7Thyroid Neoplasms 6Neoplasm Metastasis 6Colorectal Neoplasms 6Ovarian Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Thyroid Diseases 4Thoracic Neoplasms 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Prostatic Neoplasms 4Neuroblastoma 4Neoplasms by Site 4Multiple Endocrine Neoplasia Type 1 4Lung Diseases 4

Interventions

Thyrotropin Alfa 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Differentiated Thyroid Cancer × Endocrine × Clear all
NCT07453225 2026-03-05

Empirical Radioactive Iodine Therapy in DTC

Assiut University

Phase 1/2 Not yet recruiting
100 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05745363 2025-12-16

Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Completed
33 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT04137185 2024-03-06

Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 1/2 Completed
64 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡